Mallinckrodt Ard Drug Patent Portfolio

Mallinckrodt Ard owns 2 orange book drugs protected by 1 US patent Given below is the list of Mallinckrodt Ard's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11752199 Methods of modulating pericytes 25 Feb, 2041
Active


Given below is the list of recent legal activities going on the following drug patents of Mallinckrodt Ard.

Activity Date Patent Number
Patent litigations
Patent Issue Date Used in PTA Calculation 12 Sep, 2023 US11752199
Email Notification 12 Sep, 2023 US11752199
Recordation of Patent Grant Mailed 12 Sep, 2023 US11752199
Recordation of Patent eGrant 12 Sep, 2023 US11752199
Sequence Moved to Public Database 12 Sep, 2023 US11752199
Mail Patent eGrant Notification 12 Sep, 2023 US11752199
Patent eGrant Notification 12 Sep, 2023 US11752199
Email Notification 24 Aug, 2023 US11752199
Issue Notification Mailed 23 Aug, 2023 US11752199
Application Is Considered Ready for Issue 02 Aug, 2023 US11752199
Dispatch to FDC 02 Aug, 2023 US11752199
Issue Fee Payment Received 01 Aug, 2023 US11752199
Issue Fee Payment Verified 01 Aug, 2023 US11752199
Sequence Forwarded to Pubs on Tape 03 May, 2023 US11752199
Mail Notice of Allowance 02 May, 2023 US11752199


Mallinckrodt Ard's Family Patents


Family Patents



Mallinckrodt Ard Drug List

Given below is the complete list of Mallinckrodt Ard's drugs and the patents protecting them.


1. Acthar Gel

Acthar Gel is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11752199 Methods of modulating pericytes 25 Feb, 2041
(16 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Acthar Gel's drug page


2. Acthar Gel (autoinjector)

Acthar Gel (autoinjector) is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11752199 Methods of modulating pericytes 25 Feb, 2041
(16 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Acthar Gel (autoinjector)'s drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List